Clinical Trial Update: ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness [NA]

View source ↗

Summary

An ongoing neoadjuvant breast cancer trial (ABCSG 61/TEODOR) investigates treatment optimization guided by circulating tumor DNA and endocrine responsiveness in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Early and Locally Advanced Breast Cancer | NA | Status: RECRUITING